Pharma Industry: Why BIM Can Become a Digital Transformation Cornerstone

Building information modeling (BIM) processes with federated 3D models and centralized common data environments (CDEs) are well-accepted norms in project delivery. Yet, the benefits derived from this digitalization favor the engineering companies over the manufacturing owner. Moreover, the owner's transformation focus is mostly on digitizing highly regulated drug releases and manufacturing performance. Converging these two digital approaches is not often seen as a priority. Yet, it may be a foundational step toward a successful digital transformation for businesses and their people. We’ll make the case for data convergence between digital assets (descriptive digital twins) and manufacturing data and analytics to solve business problems, like accessing the right information and documentation without time loss. We’ll share how the human-centered approach made visible the foundational benefit of BIM by linking objects to information using BIM 360 (collaborate) and data fusion technologies, and which KPIs can demonstrate value.